Teva Pharmaceuticals
Anda, Inc., is now part of Teva Pharmaceuticals, a leader in global generics, committed to transforming global healthcare.
What is Anda Pharma?
An Abbreviated New Drug Application (ANDA) is a written request to the U.S. Food and Drug Administration (FDA) to manufacture and market a generic drug in the United States.
Does Teva own Anda?
Anda Today On October 3, 2016, Anda became an independent wholly owned subsidiary of Teva Pharmaceutical Industries Ltd., and is one of the leading pharmaceutical distributors within the United States, Puerto Rico and the Virgin Islands.
Who bought Anda?
Teva Pharmaceutical Industries
Anda was acquired by Teva Pharmaceutical Industries for $500M on Aug 3, 2016 .
Who are the big 3 wholesalers?
The exhibits below—2 of the 136 in our new report—provide a look at the revenues and market share of the Big Three wholesalers: AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation.
Does Teva own Allergan?
In 2016, Allergan sold its generic business, Actavis, to Teva Pharmaceuticals for $40.5 billion. In June 2019, U.S. pharmaceutical company AbbVie announced it had reached an agreement to acquire Allergan for $63 billion….Allergan.
| Type | Subsidiary of AbbVie Inc. |
|---|---|
| Parent | AbbVie Inc. |
| Website | |
| Footnotes / references |
What is pharmaceutical distribution?
Pharmaceutical distribution is the wholesaler/middleman link in the drug distribution chain. These companies buy drugs directly from the big suppliers, warehouse them, and then distribute them to the tens of thousands of pharmacies throughout the United States.
What is Anda Inc?
Anda, Inc. is now part of Teva Pharmaceuticals, a leader in global generics, committed to transforming global healthcare.
What is Anda drug company?
An abbreviated new drug application (ANDA) contains data which is submitted to FDA for the review and potential approval of a generic drug product. Once approved, an applicant may manufacture and market the generic drug product to provide a safe, effective, lower cost alternative to the brand-name drug it references.
